e-learning
resources
Glasgow 2004
Monday 06.09.2004
Modern techniques bringing new insights into cystic fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Correlation between decrease of leukotriene B-4 and reactive protein C in cystic fibrosis patients
E. Bucchioni, D. Costantini, F. Blasi, T. Cappelletti, A. Brivio, C. Colombo, L. Allegra (Milan, Italy)
Source:
Annual Congress 2004 - Modern techniques bringing new insights into cystic fibrosis
Session:
Modern techniques bringing new insights into cystic fibrosis
Session type:
Thematic Poster Session
Number:
2388
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Bucchioni, D. Costantini, F. Blasi, T. Cappelletti, A. Brivio, C. Colombo, L. Allegra (Milan, Italy). Correlation between decrease of leukotriene B-4 and reactive protein C in cystic fibrosis patients. Eur Respir J 2004; 24: Suppl. 48, 2388
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Definition and history of sarcoidosis
Related content which might interest you:
Reduced 15-lipoxygenase 2 and lipoxin A4/leukotriene B4 ratio in children with cystic fibrosis
Source: Eur Respir J 2014; 44: 394-404
Year: 2014
Increased intraalveolar level of soluble endothelial protein C receptor in patients with interstitial lung disease
Source: Eur Respir J 2004; 24: Suppl. 48, 319s
Year: 2004
Correlation between inflammatory and oxidation markers in adults with cystic fibrosis
Source: Annual Congress 2008 - Cystic fibrosis: a disease with many aspects
Year: 2008
The expression of calgranulin B in idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010
Airway bacterial colonization is associated with low vitamin D serum levels in children with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013
Induced sputum glutathione levels are decreased in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2001; 18: Suppl. 33, 409s
Year: 2001
Decreased BCL-2 expression in alveolar macrophages of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010
Cystic fibrosis neutrophils have normal intrinsic reactive oxygen species generation
Source: Eur Respir J 2010; 35: 1264-1272
Year: 2010
Oxidation contributes to low glutathione in the airways of children with cystic fibrosis
Source: Eur Respir J 2014; 44: 122-129
Year: 2014
Inflammation in cystic fibrosis patients: study of the eicosanoid pathway and severity correlations.
Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis
Year: 2021
α1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients
Source: Eur Respir J 2007; 29: 240-250
Year: 2007
Fluticasone reduces IL-6 and IL-8 production of cystic fibrosis bronchial epithelial cells via IKK-β kinase pathway
Source: Eur Respir J 2003; 21: 574-581
Year: 2003
High mobility group box protein 1 (HMGB1) production in highly vascularized alveolar lesions causes acute exacerbation in idiopathic pulmonary fibrosis
Source: Annual Congress 2005 - Progresses in lung fibrosis
Year: 2005
Increased alveolar soluble annexin V promotes lung inflammation and fibrosis
Source: Eur Respir J 2015; 46: 1417-1429
Year: 2015
Differential expression of IL-33 and HMGB1 in the lungs of stable cystic fibrosis patients
Source: Eur Respir J 2014; 44: 802-805
Year: 2014
Plasma level of total hydroperoxide (TH) as a marker of oxidative stress seems to be a useful index of disease severity in patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2005; 26: Suppl. 49, 335s
Year: 2005
Relationship between C reactive protein and gene and levels of alpha1-antitrypsin
Source: Annual Congress 2009 - Cell biology of lung disease
Year: 2009
Effects of a leukotriene B4 receptor antagonist on bleomycin-induced pulmonary fibrosis
Source: Eur Respir J 2009; 34: 1444-1451
Year: 2009
Targeting of cathepsin S reduces cystic fibrosis-like lung disease
Source: Eur Respir J, 53 (3) 1801523; 10.1183/13993003.01523-2018
Year: 2019
Evaluation of high sensitivity C reactive protein in patients of bronchial asthma and its correlation with exacerbation rate and pulmonary function
Source: Annual Congress 2008 - Asthma: growing understanding of influential factors
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept